-
1
-
-
1642453780
-
Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism
-
L. Linkins, P.T. Choi, and J.D. Douketis Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism Ann Intern Med 139 2003 893 900
-
(2003)
Ann Intern Med
, vol.139
, pp. 893-900
-
-
Linkins, L.1
Choi, P.T.2
Douketis, J.D.3
-
2
-
-
33744506249
-
Accuracy of coding for possible warfarin complications in hospital discharge abstracts
-
DOI 10.1016/j.thromres.2005.06.015, PII S0049384805002963
-
T. Arnason, P.S. Wells, C. van Walraven, and A.J. Forster Accuracy of coding for possible warfarin complications in hospital discharge abstracts Thromb Res 118 2006 253 262 (Pubitemid 43816665)
-
(2006)
Thrombosis Research
, vol.118
, Issue.2
, pp. 253-262
-
-
Arnason, T.1
Wells, P.S.2
Van Walraven, C.3
Forster, A.J.4
-
3
-
-
0036184165
-
Validation of diagnoses of peptic ulcers and bleeding from administrative databases: A multi-health maintenance organization study
-
DOI 10.1016/S0895-4356(01)00480-2, PII S0895435601004802
-
S.E. Andrade, J.H. Gurwitz, K.A. Chan, J.G. Donahue, A. Beck, and M. Boles Validation of diagnoses of peptic ulcers and bleeding from administrative databases: a multi-health maintenance organization study J Clin Epidemiol 55 3 Mar 2002 310 313 (Pubitemid 34195528)
-
(2002)
Journal of Clinical Epidemiology
, vol.55
, Issue.3
, pp. 310-313
-
-
Andrade, S.E.1
Gurwitz, J.H.2
Chan, K.A.3
Donahue, J.G.4
Beck, A.5
Boles, M.6
Buist, D.S.M.7
Goodman, M.8
LaCroix, A.Z.9
Levin, T.R.10
Platt, R.11
-
4
-
-
0033151642
-
Positive predictive value of ICD-9th codes for upper gastrointestinal bleeding and perforation in the Sistema Informativo Sanitario Regionale database
-
DOI 10.1016/S0895-4356(99)00004-9, PII S0895435699000049
-
C. Cattaruzzi, M.G. Troncon, L. Agostinis, and L.A. García Rodríguez Positive predictive value of ICD-9th codes for upper gastrointestinal bleeding and perforation in the Sistema Informativo Sanitario Regionale database J Clin Epidemiol 52 6 Jun 1999 499 502 (Pubitemid 29281666)
-
(1999)
Journal of Clinical Epidemiology
, vol.52
, Issue.6
, pp. 499-502
-
-
Cattaruzzi, C.1
Troncon, M.G.2
Agostinis, L.3
Garcia Rodriguez, L.A.4
-
5
-
-
57349116749
-
Effect of oral antiplatelet agents on major bleeding in users of coumarins
-
T. Schalekamp, O.H. Klungel, P.C. Souverein, and A. Boer Effect of oral antiplatelet agents on major bleeding in users of coumarins Thromb Haemost 100 2008 1076 1083
-
(2008)
Thromb Haemost
, vol.100
, pp. 1076-1083
-
-
Schalekamp, T.1
Klungel, O.H.2
Souverein, P.C.3
Boer, A.4
-
6
-
-
33745154864
-
Warfarin exposure and the risk of thromboembolic and major bleeding events among medicaid patients with atrial fibrillation
-
DOI 10.1345/aph.1G408
-
L. Boulanger, O. Hauch, M. Friedman, T. Foster, D. Dixon, and G. Wygant Warfarin exposure and the risk of thromboembolic and major bleeding events among Medicaid patients with atrial fibrillation Ann Pharmacother 40 2006 1024 1029 (Pubitemid 43890902)
-
(2006)
Annals of Pharmacotherapy
, vol.40
, Issue.6
, pp. 1024-1029
-
-
Boulanger, L.1
Hauch, O.2
Friedman, M.3
Foster, T.4
Dixon, D.5
Wygant, G.6
Menzin, J.7
-
7
-
-
23044505564
-
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients
-
DOI 10.1111/j.1538-7836.2005.01204.x
-
S. Schulman, and C. Kearon Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients J Thromb Haemost 3 2005 692 694 (Pubitemid 41647882)
-
(2005)
Journal of Thrombosis and Haemostasis
, vol.3
, Issue.4
, pp. 692-694
-
-
Schulman, S.1
Kearon, C.2
-
8
-
-
33847224191
-
Veterans' Access to and Use of Medicare and Veterans Affairs Health Care
-
D.M. Hynes, K. Koelling, K. Stroupe, N. Arnold, K. Mallin, and Sohn Min-Woong Veterans' Access to and Use of Medicare and Veterans Affairs Health Care Med Care 45 3 2007 214 223
-
(2007)
Med Care
, vol.45
, Issue.3
, pp. 214-223
-
-
Hynes, D.M.1
Koelling, K.2
Stroupe, K.3
Arnold, N.4
Mallin, K.5
Min-Woong, S.6
-
9
-
-
78649342646
-
Patient characteristics associated with oral anticoagulation control: Results of the Veterans AffaiRs Study to Improve Anticoagulation (VARIA)
-
A.J. Rose, E.M. Hylek, A. Ozonoff, A.S. Ash, J.I. Reisman, and D.R. Berlowitz Patient characteristics associated with oral anticoagulation control: Results of the Veterans AffaiRs Study to Improve Anticoagulation (VARIA) J Thromb Haemost 8 10 Oct 2010 2182 2191
-
(2010)
J Thromb Haemost
, vol.8
, Issue.10
, pp. 2182-2191
-
-
Rose, A.J.1
Hylek, E.M.2
Ozonoff, A.3
Ash, A.S.4
Reisman, J.I.5
Berlowitz, D.R.6
-
11
-
-
0344861847
-
Anticoagulation Therapy for Stroke Prevention in Atrial Fibrillation: How Well Do Randomized Trials Translate into Clinical Practice?
-
DOI 10.1001/jama.290.20.2685
-
A.S. Go, E.M. Hylek, Y. Chang, K.A. Phillips, L.E. Henault, and A.M. Capra Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice? JAMA 290 20 Nov 26 2003 2685 2692 (Pubitemid 37475596)
-
(2003)
Journal of the American Medical Association
, vol.290
, Issue.20
, pp. 2685-2692
-
-
Go, A.S.1
Hylek, E.M.2
Chang, Y.3
Phillips, K.A.4
Henault, L.E.5
Capra, A.M.6
Jensvold, N.G.7
Selby, J.V.8
Singer, D.E.9
-
12
-
-
52449129321
-
Warfarin for atrial fibrillation in community-based practise
-
A.J. Rose, A. Ozonoff, L.E. Henault, and E.M. Hylek Warfarin for atrial fibrillation in community-based practise J Thromb Haemost 6 10 Oct 2008 1647 1654
-
(2008)
J Thromb Haemost
, vol.6
, Issue.10
, pp. 1647-1654
-
-
Rose, A.J.1
Ozonoff, A.2
Henault, L.E.3
Hylek, E.M.4
-
13
-
-
77955872745
-
A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: The Euro Heart Survey
-
R. Pisters, D.A. Lane, R. Nieuwlaat, C.B. de Vos, H.J. Crijns, and G.Y. Lip A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey Chest 138 5 Nov 2010 1093 1100
-
(2010)
Chest
, vol.138
, Issue.5
, pp. 1093-1100
-
-
Pisters, R.1
Lane, D.A.2
Nieuwlaat, R.3
De Vos, C.B.4
Crijns, H.J.5
Lip, G.Y.6
-
14
-
-
0345414673
-
Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): Randomised controlled trial
-
SPORTIF-III Investigators
-
SPORTIF-III Investigators Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial Lancet 362 9397 2003 1691 1698
-
(2003)
Lancet
, vol.362
, Issue.9397
, pp. 1691-1698
-
-
-
15
-
-
13444309949
-
Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: A randomized trial
-
G.W. Albers, H.C. Diener, L. Frison, M. Grind, M. Nevinson, and S. Partridge Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial JAMA 293 6 Feb 9 2005 690 698
-
(2005)
JAMA
, vol.293
, Issue.6
, pp. 690-698
-
-
Albers, G.W.1
Diener, H.C.2
Frison, L.3
Grind, M.4
Nevinson, M.5
Partridge, S.6
-
16
-
-
33744945247
-
Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): A randomised controlled trial
-
ACTIVE Writing Group of the ACTIVE Investigators
-
ACTIVE Writing Group of the ACTIVE Investigators S. Connolly, J. Pogue, R. Hart, M. Pfeffer, and S. Hohnloser Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial Lancet 367 9526 Jun 10 2006 1903 1912
-
(2006)
Lancet
, vol.367
, Issue.9526
, pp. 1903-1912
-
-
Connolly, S.1
Pogue, J.2
Hart, R.3
Pfeffer, M.4
Hohnloser, S.5
-
17
-
-
70349306707
-
Dabigatran versus warfarin in patients with atrial fibrillation
-
S.J. Connolly, M.D. Ezekowitz, S. Yusuf, J. Eikelboom, J. Oldgren, and A. Parekh Dabigatran versus warfarin in patients with atrial fibrillation N Engl J Med 361 12 Sep 17 2009 1139 1151
-
(2009)
N Engl J Med
, vol.361
, Issue.12
, pp. 1139-1151
-
-
Connolly, S.J.1
Ezekowitz, M.D.2
Yusuf, S.3
Eikelboom, J.4
Oldgren, J.5
Parekh, A.6
-
18
-
-
80052592404
-
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation
-
[Epub 2011 Aug 10]
-
M.R. Patel, K.W. Mahaffey, J. Garg, G. Pan, D.E. Singer, and W. Hacke Rivaroxaban versus warfarin in nonvalvular atrial fibrillation N Engl J Med 365 10 Sep 8 2011 883 891 [Epub 2011 Aug 10]
-
(2011)
N Engl J Med
, vol.365
, Issue.10
, pp. 883-891
-
-
Patel, M.R.1
Mahaffey, K.W.2
Garg, J.3
Pan, G.4
Singer, D.E.5
Hacke, W.6
-
19
-
-
80052825103
-
Apixaban versus warfarin in patients with atrial fibrillation
-
C.B. Granger, J.H. Alexander, J.J. McMurray, R.D. Lopes, E.M. Hylek, and M. Hanna Apixaban versus warfarin in patients with atrial fibrillation N Engl J Med 365 11 Sep 15 2011 981 992
-
(2011)
N Engl J Med
, vol.365
, Issue.11
, pp. 981-992
-
-
Granger, C.B.1
Alexander, J.H.2
McMurray, J.J.3
Lopes, R.D.4
Hylek, E.M.5
Hanna, M.6
-
20
-
-
0028343127
-
Risk factors for intracranial hemorrhage in outpatients taking warfarin
-
E.M. Hylek, and D.E. Singer Risk factors for intracranial hemorrhage in outpatients taking warfarin Ann Intern Med 120 1994 897 902 (Pubitemid 24179151)
-
(1994)
Annals of Internal Medicine
, vol.120
, Issue.11
, pp. 897-902
-
-
Hylek, E.M.1
Singer, D.E.2
-
21
-
-
19644400842
-
Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation
-
M.C. Fang, Y. Chang, E.M. Hylek, J. Rosand, S.M. Greenberg, and A.S. Go Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation Ann Intern Med 141 10 Nov 16 2004 745 752
-
(2004)
Ann Intern Med
, vol.141
, Issue.10
, pp. 745-752
-
-
Fang, M.C.1
Chang, Y.2
Hylek, E.M.3
Rosand, J.4
Greenberg, S.M.5
Go, A.S.6
-
22
-
-
33746765044
-
Age and the risk of warfarin-associated hemorrhage: The anticoagulation and risk factors in atrial fibrillation study
-
DOI 10.1111/j.1532-5415.2006.00828.x
-
M.C. Fang, A.S. Go, E.M. Hylek, Y. Chang, L.E. Henault, and N.G. Jensvold Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study J Am Geriatr Soc 54 8 Aug 2006 1231 1236 (Pubitemid 44166528)
-
(2006)
Journal of the American Geriatrics Society
, vol.54
, Issue.8
, pp. 1231-1236
-
-
Fang, M.C.1
Go, A.S.2
Hylek, E.M.3
Chang, Y.4
Henault, L.E.5
Jensvold, N.G.6
Singer, D.E.7
|